LC-MS analysis of serum lipidomic and metabolomic signatures in pediatric patients with acute lymphoblastic leukemia
Authors:
Preprint
- 20 November 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Acute lymphoblastic leukemia (ALL) is a prevalent hematologic malignancy that primarily affects children. The diagnosis and treatment of pediatric ALL remain challenging. This study aimed to identify differential lipids and metabolites that may hold potential for improving ALL diagnosis. Methods Serum lipidome and metabolome alterations of ALL were analyzed by comparing pediatric patients with ALL with healthy controls based on liquid chromatography high-resolution mass spectrometry analysis of serum lipidomic and metabolomic signatures. Results We identified 2,298 lipid features in the serum. Among them, 72 (3.13%) differed significantly in pediatric patients with ALL compared to healthy controls. Notably, sphingolipids (ceramide and sphingomyelin) and phospholipids exhibited the most pronounced changes. Targeted analysis of ceramides revealed significantly elevated levels of Cer 18:0 and Cer 20:0 in the serum of pediatric patients with ALL. Additionally, gut microbial-related lipids (such as sulfonolipids and fatty acid esters of hydroxy fatty acids) showed significant alterations. Metabolomic analysis identified 15 differential metabolites, indicating disrupted nucleotide and amino acid metabolism. Furthermore, the dysregulated lipids and metabolites correlated with various blood indicators, with ceramide and nucleosides positively associated with white blood cell count but negatively correlated with hemoglobin and platelet. Conclusion These findings shed light on abnormal molecular signatures contributing to pediatric ALL and may serve as potential biomarker panel for diagnosis and therapy of ALL.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Ceramide signaling in the gutMolecular and Cellular Endocrinology, 2022
- Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepositoryMetabolomics, 2021
- Development and validation of a RPLC-MS/MS method for the quantification of ceramides in human serumJournal of Chromatography B, 2021
- Elucidation of Gut Microbiota-Associated Lipids Using LC-MS/MS and 16S rRNA Sequence AnalysesiScience, 2020
- Metabolic reprogramming in childhood acute lymphoblastic leukemiaPediatric Blood & Cancer, 2020
- Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and SymbiosisCell Host & Microbe, 2019
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Development and validation of a high-throughput LC–MS/MS assay for routine measurement of molecular ceramidesAnalytical and Bioanalytical Chemistry, 2016
- Biomarker identification and pathway analysis by serum metabolomics of childhood acute lymphoblastic leukemiaClinica Chimica Acta, 2014
- Hallmarks of Cancer: The Next GenerationCell, 2011